-

Öz

Parçalara ayrılmış implante edilebilir damar yolu açma aparatı enfeksiyonunu takip eden bir Staphylococcus lugdunensis Staphylococcus lugdunensis bakteriyemisi olgusunu bildirdik. Bu olguda özellikle protez cihaz kullanan immünitesi baskılanmış hastalarda gelişen S. lugdunensis’in virulansı vurgulamakla birlikte bu mikroorganizmanın kandan izole edildiğinde kontaminasyon/enfeksiyonunu ayırımının önemine dikkat çekildi. İhtiyaç kalmadığında damar yolu açma aparatlarının hemen çıkarılmasının kateter enfeksiyonlarının önlenmesinde arz ettiği önem ayrıca belirtildi

Anahtar Kelimeler

• Staphylococcus lugdunensis, bakteriyemi, damar yolu açma aparatı

Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device

Abstract

We report a case of Staphylococcus lugdunensis bacteraemia following infection of a fragmented totally implantable vascular access device. This report highlights the virulence of S. lugdunensis especially in immunosuppressed patients with prosthetic devices as well as the importance of distinguishing between contamination and blood stream infection when this organism is cultured from blood. The importance of prompt removal of implantable vascular access devices when they are no longer required, to prevent catheter related infections is also reflected in this report. J Microbiol Infect Dis 2015;5(2): 85-88

Key words: Staphylococcus lugdunensis, bacteraemia, vascular access devices.

Keywords

• Staphylococcus lugdunensis, bacteraemia, vascular access devices

Kaynakça

1. Choi S, Chung J, Lee EJ, et al. Incidence, Characteristics, and outcomes of Staphylococcus lugdunensis bacteraemia. J Clin Microb 2010;48:3346-3349.
2. Babu E, Oropello J. Staphylococcus lugdunensis: The coagulase
3. negative staphylococcus you don’t want to ignore. Expert review of anti-infective therapy. 2011;9:901-907.
4. Frank KL, del Pozo J, Patel R. From clinical microbiology to infection pathogenesis: How daring to be different works for Staphylococcus lugdunensis. Clin Microbiology Review 2008;21:111-33.
5. Herchline T, Ayers L. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiology 1991;29:419-421.
6. Freney J, Brun Y, Bes M, et al. Staphylococcus lugdunensis sp.nov. and Staphylococcus schleiferi sp.nov., Two Species from Human Clincal Specimens. Int J System Evolution Microbiol 1988;38:168-172.
7. Royle T, Davies R, Gannon M. Totally implantable vascular access device-20 years’ experience of implantation in cystic fibrosis patients. Ann R Coll Surg Engl 2008;90:679-684.
8. Di Carlo I, Biffi R. Totally Implantable Venous Access Devices: Management in Mid- and Long-term Clinical Setting. Italia: Springer-Verlag, 2012:201-204.

9. Elzi L, Babouee B, Vogeli N, et al. How to discriminate contamination
10. from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect 2012;18:E355-E361.
11. Rahkonen M, Luttinen M, Koskela. True bacteramias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants. Eur J Clin Microbiol Infect Dis 2012;31:2659-2644.